112 related articles for article (PubMed ID: 11144879)
1. Multiforme skin lesions in Yekatit 12 Hospital, 1976-1994.
Gessesse B; Mulugeta E
Ethiop Med J; 2000 Jan; 38(1):43-7. PubMed ID: 11144879
[TBL] [Abstract][Full Text] [Related]
2. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
Kuaban C; Bercion R; Koulla-Shiro S
East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
[TBL] [Abstract][Full Text] [Related]
3. Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania.
Dukes CS; Sugarman J; Cegielski JP; Lallinger GJ; Mwakyusa DH
Trop Geogr Med; 1992 Oct; 44(4):308-11. PubMed ID: 1284179
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis.
Nunn P; Kibuga D; Gathua S; Brindle R; Imalingat A; Wasunna K; Lucas S; Gilks C; Omwega M; Were J
Lancet; 1991 Mar; 337(8742):627-30. PubMed ID: 1705647
[TBL] [Abstract][Full Text] [Related]
5. Two years review of cutaneous adverse drug reaction from first line anti-tuberculous drugs.
Tan WC; Ong CK; Kang SC; Razak MA
Med J Malaysia; 2007 Jun; 62(2):143-6. PubMed ID: 18705448
[TBL] [Abstract][Full Text] [Related]
6. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
7. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
8. Tolerability of anti-tuberculosis treatment and HIV serostatus.
Lanternier F; Dalban C; Perez L; Bricaire F; Costagliola D; Caumes E
Int J Tuberc Lung Dis; 2007 Nov; 11(11):1203-9. PubMed ID: 17958982
[TBL] [Abstract][Full Text] [Related]
9. Life-threatening cutaneous reactions to thiacetazone-containing antituberculosis treatment in Kumasi, Ghana.
Lawn SD; Frimpong EH; Acheampong JW
West Afr J Med; 1999; 18(4):249-53. PubMed ID: 10734785
[TBL] [Abstract][Full Text] [Related]
10. [HIV seroprevalence in patients with tuberculosis].
Nagai H; Kawabe Y; Nagayama N; Tanaka Y; Nishiyama M; Suzuki M; Masuda K; Baba M; Hori A; Tamura A; Akagawa S; Machida K; Kurashima A; Yotsumoto H; Mori M; Kimura S
Kekkaku; 2001 Nov; 76(11):679-84. PubMed ID: 11766358
[TBL] [Abstract][Full Text] [Related]
11. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.
Reechaipichitkul W
Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):570-4. PubMed ID: 12693593
[TBL] [Abstract][Full Text] [Related]
12. Eosinophils in skin lesions of erythema multiforme.
Patterson JW; Parsons JM; Blaylock WK; Mills AS
Arch Pathol Lab Med; 1989 Jan; 113(1):36-9. PubMed ID: 2910224
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness and total costs of three alternative strategies for the prevention and management of severe skin reactions attributable to thiacetazone in the treatment of Human Immunodeficiency Virus positive patients with tuberculosis in Kenya.
van Gorkom J; Kibuga DK
Tuber Lung Dis; 1996 Feb; 77(1):30-6. PubMed ID: 8733411
[TBL] [Abstract][Full Text] [Related]
14. [Skin toxicity of thiacetazone (TB1) at a hospital service in Dakar].
Dieng MT; Ndiaye B; Camara C
Dakar Med; 2001; 46(1):1-3. PubMed ID: 15773145
[TBL] [Abstract][Full Text] [Related]
15. Severe hypersensitivity reactions among HIV-seropositive patients with tuberculosis treated with thioacetazone.
Wkly Epidemiol Rec; 1992 Jan; 67(1-2):1-3. PubMed ID: 1371055
[No Abstract] [Full Text] [Related]
16. First-line antituberculosis drug resistance prevalence and its pattern among HIV-infected patients in the national referral tuberculosis centre, Iran.
Tabarsi P; Chitsaz E; Moradi A; Baghaei P; Farnia P; Marjani M; Irannejad P; Mansouri D; Masjedi M
Int J STD AIDS; 2009 Aug; 20(8):566-70. PubMed ID: 19625590
[TBL] [Abstract][Full Text] [Related]
17. [Lyell syndrome in Senegal: responsibility of thiacetazone].
Mame Thierno D; On S; Thierno Ndiaye S; Ndiaye B
Ann Dermatol Venereol; 2001 Dec; 128(12):1305-7. PubMed ID: 11908132
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced oral erythema multiforme. Results of a long-term retrospective study.
Gebel K; Hornstein OP
Dermatologica; 1984; 168(1):35-40. PubMed ID: 6698263
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of active pulmonary tuberculosis in human immunodeficiency virus seropositive adult patients in University College Hospital, Ibadan, Nigeria.
Awoyemi OB; Ige OM; Onadeko BO
Afr J Med Med Sci; 2002 Dec; 31(4):329-32. PubMed ID: 15027773
[TBL] [Abstract][Full Text] [Related]
20. Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens.
Ho CC; Chen YC; Hu FC; Yu CJ; Yang PC; Luh KT
Clin Infect Dis; 2009 Jun; 48(11):1526-33. PubMed ID: 19400686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
